Nobel medicine prize honours US and German scientists for optogenetics work
American scientist Karl Deisseroth and Germans Peter Hegemann and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine. The Nobel Assembly of Sweden’s Karolinska Institute recognized them for their pioneering discoveries in optogenetics, a technique that uses light to control nerve signals.

Briefing Summary
AI-generatedAmerican scientist Karl Deisseroth and Germans Peter Hegemann and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine. The Nobel Assembly of Sweden’s Karolinska Institute recognized them for their pioneering discoveries in optogenetics, a technique that uses light to control nerve signals. This breakthrough allows researchers to understand how specific nerve cells contribute to various brain functions, such as learning, fear, addiction, and movement. Optogenetics has fundamentally changed brain research, enabling scientists to switch nerve cell activity on or off in living brains and map neural pathways with unprecedented precision. The method is widely used globally and holds potential for advancements like improved cochlear implants.
Article analysis
Model · rule-basedKey claims
5 extractedOptogenetics makes it possible to switch on or off the activity of individual nerve cells in a living brain.
Optogenetics has fundamentally altered our understanding of the brain and helps solve mysteries of how it works.
Optogenetics involves controlling nerve signals with light to understand how specific cell types contribute to behaviors.
Karl Deisseroth, Peter Hegemann, and Georg Nagel won the 2026 Nobel Prize in Physiology or Medicine for their discoveries in optogenetics.
Researchers hope optogenetics could improve cochlear implants by allowing more precise stimulation of the auditory nerve.